Analytical Data
-
Gene name
CCNG2
- Application
-
Alternative Names
CCNG 2; Ccng2; CCNG2 Protein; CCNG2_HUMAN; Cyclin-G2; CyclinG2
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16589
-
Expression Region
1-344aa
-
AA Sequence
MKDLGAEHLAGHEGVQLLGLLNVYLEQEERFQPREKGLSLIEATPENDNTLCPGLRNAKVEDLRSLANFFGSCTETFVLAVNILDRFLALMKVKPKHLSCIGVCSFLLAARIVEEDCNIPSTHDVIRISQCKCTASDIKRMEKIISEKLHYELEATTALNFLHLYHTIILCHTSERKEILSLDKLEAQLKACNCRLIFSKAKPSVLALCLLNLEVETLKSVELLEILLLVKKHSKINDTEFFYWRELVSKCLAEYSSPECCKPDLKKLVWIVSRRTAQNLHNSYYSVPELPTIPEGGCFDESESSVAQAGVQWPDLSSFQPPPTRFKRFSCLSLRSSWDYSSWT
-
Molecular Weight
63.58 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCNG2, or Cyclin G2, is a member of the cyclin family, which plays a critical role in the regulation of the cell cycle and various cellular processes. It has been implicated in tumor suppression and has been studied for its involvement in several types of cancer, including breast and colorectal cancers. The regulation of CCNG2 expression and its protein stability are influenced by different signaling pathways, highlighting its potential as a biomarker for cancer diagnosis and prognosis. Research on recombinant CCNG2 proteins aims to investigate their structure and function, facilitate the understanding of its biological roles, and explore its therapeutic possibilities. By producing CCNG2 in recombinant systems, researchers can obtain large quantities of the protein for biochemical assays, structural studies, and drug screening. The elucidation of CCNG2’s interaction with cellular partners and its regulatory mechanisms is essential for understanding its role in tumorigenesis. Overall, the study of CCNG2 recombinant proteins presents significant opportunities for advancing cancer research and developing targeted therapies.
